227 related articles for article (PubMed ID: 21555591)
1. Control of mTORC1 signaling by the Opitz syndrome protein MID1.
Liu E; Knutzen CA; Krauss S; Schweiger S; Chiang GG
Proc Natl Acad Sci U S A; 2011 May; 108(21):8680-5. PubMed ID: 21555591
[TBL] [Abstract][Full Text] [Related]
2. MID1 catalyzes the ubiquitination of protein phosphatase 2A and mutations within its Bbox1 domain disrupt polyubiquitination of alpha4 but not of PP2Ac.
Du H; Wu K; Didoronkute A; Levy MV; Todi N; Shchelokova A; Massiah MA
PLoS One; 2014; 9(9):e107428. PubMed ID: 25207814
[TBL] [Abstract][Full Text] [Related]
3. Protein phosphatase 2A (PP2A)-specific ubiquitin ligase MID1 is a sequence-dependent regulator of translation efficiency controlling 3-phosphoinositide-dependent protein kinase-1 (PDPK-1).
Aranda-Orgillés B; Rutschow D; Zeller R; Karagiannidis AI; Köhler A; Chen C; Wilson T; Krause S; Roepcke S; Lilley D; Schneider R; Schweiger S
J Biol Chem; 2011 Nov; 286(46):39945-57. PubMed ID: 21930711
[TBL] [Abstract][Full Text] [Related]
4. The E3 ubiquitin ligase MID1/TRIM18 promotes atypical ubiquitination of the BRCA2-associated factor 35, BRAF35.
Zanchetta ME; Napolitano LMR; Maddalo D; Meroni G
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1844-1854. PubMed ID: 28760657
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional observations of the P151L MID1 mutation reveal alpha4 plays a significant role in X-linked Opitz Syndrome.
Wright KM; Du H; Massiah MA
FEBS J; 2017 Jul; 284(14):2183-2193. PubMed ID: 28548391
[TBL] [Abstract][Full Text] [Related]
6. Active transport of the ubiquitin ligase MID1 along the microtubules is regulated by protein phosphatase 2A.
Aranda-Orgillés B; Aigner J; Kunath M; Lurz R; Schneider R; Schweiger S
PLoS One; 2008; 3(10):e3507. PubMed ID: 18949047
[TBL] [Abstract][Full Text] [Related]
7. Mig12, a novel Opitz syndrome gene product partner, is expressed in the embryonic ventral midline and co-operates with Mid1 to bundle and stabilize microtubules.
Berti C; Fontanella B; Ferrentino R; Meroni G
BMC Cell Biol; 2004 Feb; 5():9. PubMed ID: 15070402
[TBL] [Abstract][Full Text] [Related]
8. A MID1 mutation associated with reduced penetrance of X-linked Opitz G/BBB syndrome.
Ruiter M; Kamsteeg EJ; Meroni G; de Vries BBA
Clin Dysmorphol; 2010 Oct; 19(4):195-197. PubMed ID: 20671548
[TBL] [Abstract][Full Text] [Related]
9. The Opitz syndrome gene product MID1 assembles a microtubule-associated ribonucleoprotein complex.
Aranda-Orgillés B; Trockenbacher A; Winter J; Aigner J; Köhler A; Jastrzebska E; Stahl J; Müller EC; Otto A; Wanker EE; Schneider R; Schweiger S
Hum Genet; 2008 Mar; 123(2):163-76. PubMed ID: 18172692
[TBL] [Abstract][Full Text] [Related]
10. Complex rearrangement of the exon 6 genomic region among Opitz G/BBB Syndrome MID1 alterations.
Migliore C; Athanasakis E; Dahoun S; Wonkam A; Lees M; Calabrese O; Connell F; Lynch SA; Izzi C; Pompilii E; Thakur S; van Maarle M; Wilson LC; Meroni G
Eur J Med Genet; 2013 Aug; 56(8):404-10. PubMed ID: 23791568
[TBL] [Abstract][Full Text] [Related]
11. The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity.
Collison A; Hatchwell L; Verrills N; Wark PA; de Siqueira AP; Tooze M; Carpenter H; Don AS; Morris JC; Zimmermann N; Bartlett NW; Rothenberg ME; Johnston SL; Foster PS; Mattes J
Nat Med; 2013 Feb; 19(2):232-7. PubMed ID: 23334847
[TBL] [Abstract][Full Text] [Related]
12. The MID1 protein is a central player during development and in disease.
Winter J; Basilicata MF; Stemmler MP; Krauss S
Front Biosci (Landmark Ed); 2016 Jan; 21(3):664-82. PubMed ID: 26709798
[TBL] [Abstract][Full Text] [Related]
13. X-linked microtubule-associated protein, Mid1, regulates axon development.
Lu T; Chen R; Cox TC; Moldrich RX; Kurniawan N; Tan G; Perry JK; Ashworth A; Bartlett PF; Xu L; Zhang J; Lu B; Wu M; Shen Q; Liu Y; Richards LJ; Xiong Z
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19131-6. PubMed ID: 24194544
[TBL] [Abstract][Full Text] [Related]
14. mTORC1 signaling requires proteasomal function and the involvement of CUL4-DDB1 ubiquitin E3 ligase.
Ghosh P; Wu M; Zhang H; Sun H
Cell Cycle; 2008 Feb; 7(3):373-81. PubMed ID: 18235224
[TBL] [Abstract][Full Text] [Related]
15. A structure-function study of MID1 mutations associated with a mild Opitz phenotype.
Mnayer L; Khuri S; Merheby HA; Meroni G; Elsas LJ
Mol Genet Metab; 2006 Mar; 87(3):198-203. PubMed ID: 16378742
[TBL] [Abstract][Full Text] [Related]
16. Novel mTORC1 Mechanism Suggests Therapeutic Targets for COMPopathies.
Posey KL; Coustry F; Veerisetty AC; Hossain MG; Gambello MJ; Hecht JT
Am J Pathol; 2019 Jan; 189(1):132-146. PubMed ID: 30553437
[TBL] [Abstract][Full Text] [Related]
17. PP2A inhibitor SET promotes mTORC1 and Bmi1 signaling through Akt activation and maintains the colony-formation ability of cancer cells.
Kohyanagi N; Kitamura N; Ikeda S; Shibutani S; Sato K; Ohama T
J Biol Chem; 2024 Jan; 300(1):105584. PubMed ID: 38141761
[TBL] [Abstract][Full Text] [Related]
18. The MID1 E3 ligase catalyzes the polyubiquitination of Alpha4 (α4), a regulatory subunit of protein phosphatase 2A (PP2A): novel insights into MID1-mediated regulation of PP2A.
Du H; Huang Y; Zaghlula M; Walters E; Cox TC; Massiah MA
J Biol Chem; 2013 Jul; 288(29):21341-21350. PubMed ID: 23740247
[TBL] [Abstract][Full Text] [Related]
19. MID1-PP2A complex functions as new insights in human lung adenocarcinoma.
Zhang L; Li J; Lv X; Guo T; Li W; Zhang J
J Cancer Res Clin Oncol; 2018 May; 144(5):855-864. PubMed ID: 29450633
[TBL] [Abstract][Full Text] [Related]
20. mTORC1 signaling can regulate growth factor activation of p44/42 mitogen-activated protein kinases through protein phosphatase 2A.
Harwood FC; Shu L; Houghton PJ
J Biol Chem; 2008 Feb; 283(5):2575-85. PubMed ID: 18056704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
